Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1516-1519, July 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qureshi, S. A.
Right arrow Articles by Zaman, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qureshi, S. A.
Right arrow Articles by Zaman, H.

The Effect of Small Doses of Prednisolone on the Incidence of Subcutaneous Sarcomas Induced by 3-Methylcholanthrene in Virgin Female Swiss Mice

Shafiq A. Qureshi1,2 and Habibuz Zaman

Department of Pathology, Jinnah Postgraduate Medical Center, Karachi, Pakistan

The effect of small doses of prednisolone on the incidence of chemically induced subcutaneous sarcomas by 3-methylcholanthrene in virgin female Swiss mice was studied. Each animal received, in the middle of its back, a single s.c. injection of 2 mg of 3-methylcholanthrene dissolved in 0.3 ml of trioctanoin. Dosages of 0.083, 0.050, and 0.035 mg of prednisolone contained in 0.05 ml of normal saline were given by daily i.p. injections to all the test animals for 20 weeks. Each of the control animals received i.p. injections of 0.05 ml of normal saline daily for the same period. The animals were weighed at weekly intervals. Animals from the test group showed a 7% decrease in body weight from the 2nd to the 6th week. Later these animals gained in weight at the same rate as the control animals. This subsequent increase in weight in the prednisolone-treated animals was not related to any obvious evidence of edema. Three animals of the control group presented tumors at the end of the 6th week, whereas the 1st sarcoma in the test group was detected on palpation at the end of the 10th week. All tumors were allowed to grow for a further period of 2 weeks following their initial recognition. The respective animals were then sacrificed and sections of the masses examined under the microscope. The experiment was terminated at the end of 20 weeks. All of the 23 surviving control animals developed tumors by the end of the 16th week. Thus there was a 100% yield of tumors in the control group of animals; on the other hand, only 20 of the 35 surviving test animals developed tumors, so the yield of tumors in the test group of animals was only 57.1%. This highly significant inhibitory effect of prednisolone on tumorigenesis was apparently also reflected in the size and histologic appearances of the tumors. The tumors in the prednisolone-treated group were smaller and appeared histologically less malignant.

1 Submitted in partial fulfilment of the requirements of the Master of Science degree.

2 Present address: Fatima Jinnah Tuberculosis Sanatorium, Quetta, West Pakistan.

Received 7/ 1/65. Revised 1/19/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.